Correlation Between Lipocine and BioNTech
Can any of the company-specific risk be diversified away by investing in both Lipocine and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and BioNTech SE, you can compare the effects of market volatilities on Lipocine and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and BioNTech.
Diversification Opportunities for Lipocine and BioNTech
Poor diversification
The 3 months correlation between Lipocine and BioNTech is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Lipocine i.e., Lipocine and BioNTech go up and down completely randomly.
Pair Corralation between Lipocine and BioNTech
Given the investment horizon of 90 days Lipocine is expected to under-perform the BioNTech. In addition to that, Lipocine is 1.6 times more volatile than BioNTech SE. It trades about -0.05 of its total potential returns per unit of risk. BioNTech SE is currently generating about 0.1 per unit of volatility. If you would invest 11,326 in BioNTech SE on August 28, 2024 and sell it today you would earn a total of 750.00 from holding BioNTech SE or generate 6.62% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Lipocine vs. BioNTech SE
Performance |
Timeline |
Lipocine |
BioNTech SE |
Lipocine and BioNTech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and BioNTech
The main advantage of trading using opposite Lipocine and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.Lipocine vs. Capricor Therapeutics | Lipocine vs. Soleno Therapeutics | Lipocine vs. Bio Path Holdings | Lipocine vs. Moleculin Biotech |
BioNTech vs. Novavax | BioNTech vs. Ginkgo Bioworks Holdings | BioNTech vs. Crispr Therapeutics AG | BioNTech vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |